Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration.
暂无分享,去创建一个
D. Adams | Koji Ochiai | Satoshi Takita | T. Eiraku | A. Kojima | K. Iwase | T. Kishi | T. Yasue | Y. Kohno | A. Ohinata | Yuichi Yageta